About this episode
In What's Trending in Aesthetics? we discuss the topics doing the rounds on social media, in injector forums and in the news: the controversies, big stories and themes getting our industry talking.
In Chapter 12 we discuss the decline of HA filler use around the world and the rise of biostimulators, and predict a potentially serious problem this trend could create.
We reflect on how these trends intersect with market consolidation and the pressures on clinics and suppliers, the risks of counterfeit devices and products, and the shifting role of pharmaceutical reps.
We finish by exploring the ramifications of the FDA's decision on compounded GLP-1 medications in the USA.
What you'll learn
- Why HA filler use is declining and biostimulators are rising
- The risks of overusing biostimulators
- How to spot the dangers of counterfeit devices and products
- How economic pressure is changing clinics and suppliers
- The changing role of pharma reps
- What the FDA's compounded GLP-1 decision means
Topics
- What's trending
- Biostimulators
- Dermal fillers
- Counterfeit products
- Industry news
- GLP-1
- FDA
Full transcript
The full transcript for this episode is coming soon.